Human LPAR1 Full Length Protein (VLP)
Human LPAR1 Full Length Protein (VLP) (LP1-H52P3) is expressed from human 293 cells (HEK293) . It contains AA Ala 2 - Val 364 (Accession # Q92633) .
Product Specifications
Background
Receptor for lysophosphatidic acid (LPA) . Plays a role in the reorganization of the actin cytoskeleton, cell migration, differentiation and proliferation, and thereby contributes to the responses to tissue damage and infectious agents. Activates downstream signaling cascades via the G (i) /G (o), G12/G13, and G (q) families of heteromeric G proteins. Signaling inhibits adenylyl cyclase activity and decreases cellular cAMP levels.
Specifications
This protein .
Accession Number
Q92633
Expression Region
Ala 2 - Val 364
Host
HEK293
Target
LPAR1
Conjugation
Unconjugated
Tag
-
Source
Human
Stability
● The product MUST be stored at -70°C or lower upon receipt; ● -70°C for 12 months under sterile conditions.
Endotoxin
1.0 EU per μg
Purity
80%
Bioactivity
Immobilized Human LPAR1 Full Length Protein (VLP) (Cat. No. LP1-H52P3) at 5 μg/mL (100 μL/well) can bind Anti-LPAR1 Antibody, Human IgG1 with a linear range of 0.2-31 ng/mL (QC tested).
Format
Liquid
Buffer
PBS, Arginine, pH7.4
Additives
Trehalose
Shipping Conditions
Dry ice
Storage Conditions
-70°C
Package Size
250ug*2
Product Datasheet
Https://www.acrobiosystems.com/static/main/products/pdf/ds/LP1-H52P3.pdf
Species
Human
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
EIA07764Ca 96 Well
Canine leucine rich repeat transmembrane neuronal 1 (LRRTM1) ELISA kit
Ask
View Details 
